Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Trinean wins 25.000 euro for disposables production

Trinean won the “Time for a Boost 2015” competition organized by Test and Measurement Solutions. CEO Kurt Hensen handed a cheque of 25 000 euro to…


Congrats to Biocartis!

The Mechelen-based biotech company Biocartis starts its IPO adventure. The demand for shares was 6,5 times higher than the offer. Biocartis gather…


Got arthritis? DNAlytics has an app for it!

Approximately 30% of patients with undifferentiated arthritis develop rheumatoid arthritis - a chronic, inflammatory disease causing deformity of …

POPULAR TAGS

Biocartis CEO steps down, company announces strong 2016 results

Written by LVS on in the category news with the tags .


In a press release stating strong annual results for the cancer diagnostic producer, Biocartis also announced a change in its top management position. Its current CEO, Rudi Pauwels, has expressed his preference to focus on the longer term strategy of Biocartis, including a pathway towards a Next-Generation Sequencing based product offering. Pauwels will act as chairman of a new strategy committee of the Board. Hilde Windels, currently Deputy CEO, will assume the role of CEO until a successor is on board.

According to the numbers, Biocartis is in excellent shape. While hoping to install 175 new Idylla instruments in 2016, the company was easily able to beat its goal, installing 224 new consoles. Biocartis also sold 7.5 times more diagnostic cartridges compared to the preceding year.

In the meantime the company keeps on releasing new diagnostic cartridges. Biocartis announced the launch of its third liquid biopsy test, the ctNRAS-BRAF-EGFR S492R Mutation Assay (RUO) for metastatic colorectal cancer, developed in collaboration with Merck. The company now has a total of 9 diagnostic tests for its Idylla platform on the market.

More news on Biocartis

Read more about: .

RELATED ARTICLES
Trinean wins 25.000 euro for disposables production

Trinean won the “Time for a Boost 2015” competition organized by Test and Measurement Solutions. CEO Kurt Hensen handed a cheque of 25 000 euro to…


Congrats to Biocartis!

The Mechelen-based biotech company Biocartis starts its IPO adventure. The demand for shares was 6,5 times higher than the offer. Biocartis gather…


Got arthritis? DNAlytics has an app for it!

Approximately 30% of patients with undifferentiated arthritis develop rheumatoid arthritis - a chronic, inflammatory disease causing deformity of …

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

V-Bio Ventures Biowin GSK KU Leuven UGent XpandInnovation Flanders.bio Janssen Turnstone Itera Life Science

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.